PARNAX LAB LTD. - 506128 - Compliance As Per Regulation 40 (9) Of Listing Obligations And Disclosure Requirement Regulations 2015.
Dear Sir, Please find enclosed herewith the Compliance Certificate Pursuant Regulation 40 (9) of Listing Obligations and Disclosure Requirement Regulations 2015 for the half year ended 31st March, 2020. Kindly take the same on your record and acknowledge the receipt of the same. Thanking you, Yours truly, PARNAX LAB LTD. - 506128 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayPARNAX LAB LTD. 2CINL36912MH1982PLC027925 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3.05 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Namrata Kambli Designation: Company Secretary and Compliance Officer EmailId: compliance@naxparlab.com Name of the Chief Financial Officer: Baiju Shah Designation: Chief Financial Officer EmailId: baijushah@naxparlab.com Date: 30/04/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. PARNAX LAB LTD. - 506128 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Parnax Lab Ltd has submitted to BSE a copy of Clarification is enclosed. PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended March 31, 2020
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here PARNAX LAB LTD. - 506128 - Clarification sought from Parnax Lab Ltd
The Exchange has sought clarification from Parnax Lab Ltd on April 21st , 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, In reference to the above captioned regulation we have received confirmation from our Registrar and Transfer Agents Link Intime Pvt. Ltd., that since there were no dematerialization request during the quarter ended 31st March, 2020, therefore Confirmation Certificate as per Regulations 74(5) is not applicable to the Company. This is for your information and record. PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Namrata KambliDesignation :- Company Secretary and Compliance Officer PARNAX LAB LTD. - 506128 - Closure of Trading Window
Pursuant to BSE Circulars dated 02nd April, 2019 vide Ref No.: List/COMP/01/2019-20 please note that trading window for dealing in the securities of the Company will remain closed for all Designated Persons (as defined in the code) from 01st April, 2020 for the purpose of Consideration of Audited Financial results for the quarter and year ended 31st March, 2020. The Trading window shall open 48 hours after the Audited Financial Result for the quarter and year ended 31st March, 2020, become generally available. Kindly take the above information on your record. PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 this is to inform that in view of the directions/advisors passed by the government authorities to prevent and contain the spread of COVID- 19 and to ensure the safety and well being of employees and all stakeholders, the manufacturing units and other operations of our plant located at Baddi, Himachal Pradesh of our subsidiary company has suspended from 26.03.2020 to 31.03.2020. Kindly take the above information on your record. PARNAX LAB LTD. - 506128 - Outcome Of Board Meeting
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Monday,16th March, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of re-appointment of Mr. Tirunillai Anantharaman ( DIN: 07147028 ) as a non executive Independent director of the Company for second term of 5 consecutive years for the period starting from 31st March, 2020 to 30th March, 2025, subject to approval of the members in the ensuring Annual General Meeting. The Meeting was commenced at 4.00 p.m. and concluded at 5.00 p.m. Kindly take the same on your record.